Bank of Montreal’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bank of Montreal’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$165K	Sell	4,326 -4,888	-53%	-$170K	﹤0.01%	3077
2026 Q1	$317K	Hold	9,214	–	–	﹤0.01%	2647
2025 Q4	$304K	Sell	9,214 -10	-0.1%	-$312	﹤0.01%	2581
2025 Q3	$263K	Buy	9,224 +1,003	+12%	+$27.3K	﹤0.01%	2599
2025 Q2	$211K	Buy	8,221 +3,333	+68%	+$84.4K	﹤0.01%	2781
2025 Q1	$134K	Hold	4,888	–	–	﹤0.01%	2848
2024 Q4	$132K	Hold	4,888	–	–	﹤0.01%	2880
2024 Q3	$140K	Hold	4,888	–	–	﹤0.01%	3149
2024 Q2	$136K	Sell	4,888 -1,081	-18%	-$29K	﹤0.01%	3154
2024 Q1	$168K	Hold	5,969	–	–	﹤0.01%	3123
2023 Q4	$159K	Buy	+5,969	New	+$150K	﹤0.01%	3219

Other funds holding FTXH

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

MIM

Marshall Investment Management Littleton, Colorado $241M AUM 30.53% 1-Year Est. Return

AIP

Ameritas Investment Partners Lincoln, Nebraska $3.75B AUM 46.53% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of Montreal's FTXH Position: Q2 2026 in Review

Bank of Montreal reduced its First Trust Nasdaq Pharmaceuticals ETF (FTXH) stake by 53% in Q2 2026, selling an estimated $170K and leaving 4,326 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #3077.

Bank of Montreal first reported a position in FTXH in Q4 2023 and has held it in 11 quarters since. The position peaked at $317K in Q1 2026. 30 funds tracked by Wall St. Rank hold FTXH as of Q2 2026.

Bank of Montreal held 4,326 shares of First Trust Nasdaq Pharmaceuticals ETF worth $165K as of Q2 2026.
Bank of Montreal sold 4,888 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2026, an estimated $170K.
First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #3077 holding.
Bank of Montreal first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2023 and has held it in 11 quarters since.
Bank of Montreal's First Trust Nasdaq Pharmaceuticals ETF position peaked at $317K in Q1 2026.
30 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.